Nantahala Capital Management, LLC Astria Therapeutics, Inc. Transaction History
Nantahala Capital Management, LLC
- $1.5 Billion
- Q2 2024
A detailed history of Nantahala Capital Management, LLC transactions in Astria Therapeutics, Inc. stock. As of the latest transaction made, Nantahala Capital Management, LLC holds 675,000 shares of ATXS stock, worth $7.64 Million. This represents 0.41% of its overall portfolio holdings.
Number of Shares
675,000
Previous 675,000
-0.0%
Holding current value
$7.64 Million
Previous $6.14 Million
-0.0%
% of portfolio
0.41%
Previous 0.41%
Shares
1 transactions
Others Institutions Holding ATXS
# of Institutions
104Shares Held
49.4MCall Options Held
27.6KPut Options Held
29.7K-
Perceptive Advisors LLC New York, NY6.49MShares$73.4 Million1.71% of portfolio
-
Ra Capital Management, L.P. Boston, MA5.04MShares$57.1 Million0.69% of portfolio
-
Vr Adviser, LLC New York, NY3.61MShares$40.8 Million3.6% of portfolio
-
Fairmount Funds Management LLC Philadelphia, PA3.55MShares$40.2 Million6.42% of portfolio
-
Black Rock Inc. New York, NY3.52MShares$39.8 Million0.0% of portfolio
About Astria Therapeutics, Inc.
- Ticker ATXS
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 15,178,000
- Market Cap $172M
- Description
- Astria Therapeutics, Inc., a biopharmaceutical company, focuses on the discovery, development, and commercialization of therapeutics for rare and niche allergic, and immunological diseases in the United States. Its lead product candidate is STAR-0215, a monoclonal antibody inhibitor of plasma kallikrein, which is in preclinical development stage...